Search

everythinglearnresearchcommunity

for

Search:↓

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Curcumin may be an effective and safer anticancer agent by regulating key cell pathways.

X-ray diffraction of hair might help detect breast cancer non-invasively.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

No definitive link between finasteride and male breast cancer, but further research is needed.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Chemotherapy causes hair loss in cancer patients by affecting both growing and resting hair.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Surgeons' testosterone levels significantly increase during major head and neck cancer surgeries.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.